NPPB and pulmonary arterial hypertension: It might be useful to investigate a potential link between brain natriuretic peptide (BNP), an established biomarker of PAH severity and prognosis, and platelet bioenergetics alteration which could also reflect abnormalities of pulmonary vascular cells or cardiomyocytes and could be useful to assess PAH gravity and progression.